[Therapy of psoriasis using dehydroepiandrosterone-enanthate].
D000284:Administration, Oral; D000731:Androstanes / Q000097:blood / Q000652:urine; D002986:Clinical Trials as Topic; D003687:Dehydroepiandrosterone / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D006801:Humans; D007273:Injections, Intramuscular; D008099:Liver / Q000378:metabolism; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D010428:Pentosephosphates / Q000378:metabolism; D011565:Psoriasis / Q000188:drug therapy* / Q000378:metabolism
D000731:Androstanes; D010428:Pentosephosphates; D003687:Dehydroepiandrosterone; D005954:Glucosephosphate Dehydrogenase; D008727:Methotrexate
Zur Therapie der Psoriasis mit Dehydroepiandrosteron-Oenanthat.